Skip to Content

Saxagliptin

In the US, Saxagliptin (saxagliptin systemic) is a member of the drug class dipeptidyl peptidase 4 inhibitors and is used to treat Diabetes, Type 2.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BH03

CAS registry number (Chemical Abstracts Service)

0361442-04-8

Chemical Formula

C18-H25-N3-O2

Molecular Weight

315

Therapeutic Category

Oral antidiabetic agent: Dipeptidyl peptidase-4 (DPP-4) inhibitor, gliptin

Chemical Names

(1S,3S,5S)-2-[(2S)-Amino(3-hydroxytricyclo[3.3.1.1³,⁷]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]-hexane-3-carbonitrile (USAN)

(1S,3S,5S)-2-{(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile (WHO)

2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.1³,⁷]dec-1-yl)acetyl]-, (1S,3S,5S)- (USAN)

Foreign Names

  • Saxagliptinum (Latin)
  • Saxagliptin (German)
  • Saxagliptine (French)
  • Saxagliptina (Spanish)

Generic Names

  • Saxagliptin (OS: USAN, BAN)
  • BMS 477118 (IS)
  • OPC-262 (IS)
  • UNII-8I7IO46IVQ (IS)
  • Saxagliptin Hydrochloride (OS: BANM)
  • UNII-Z8J84YIX6L (IS)

Brand Names

  • Glyza
    Ibn Sina, Bangladesh
  • Kombiglyze XR (Saxagliptin and Metformin)
    AstraZeneca, Indonesia; AstraZeneca, Malaysia; AstraZeneca, Philippines; Bristol Myers Squibb, Israel; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, United States
  • Komboglyze (Saxagliptin and Metformin)
    AstraZeneca, Finland; AstraZeneca, Latvia
  • Onglyza
    AstraZeneca, China; AstraZeneca, Egypt; AstraZeneca, Indonesia; AstraZeneca, Lebanon; AstraZeneca, Norway; AstraZeneca, Philippines; AstraZeneca, Thailand; AstraZeneca, Vietnam; BMS, Turkey; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Russian Federation; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, United States
  • Duoglyze (Saxagliptin and Metformin)
    AstraZeneca, Switzerland
  • Kombiglyze XR (Saxagliptin and Metformin)
    AstraZeneca, Switzerland; Bristol-M.S., Argentina
  • Komboglyze (Saxagliptin and Metformin)
    AstraZeneca, Norway; Bristol Myers Squibb/Astrazeneca Eeig, Spain; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb/AstraZeneca, Germany; Bristol-Myers Squibb/AstraZeneca, United Kingdom
  • Onglyza
    AstraZeneca, Canada; AstraZeneca, Switzerland; AstraZeneca, Finland; AstraZeneca, Hong Kong; AstraZeneca, Latvia; AstraZeneca, Mexico; AstraZeneca, Malaysia; BMS Bristol-Myers Squibb, South Korea; Bristol Myers Squibb, Spain; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Israel; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, South Africa; Bristol-Myers Squibb/AstraZeneca EEIG, Denmark; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb/AstraZeneca, Germany; PharmaSwiss, Croatia (Hrvatska)

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide